<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-IQ5LBH0F</identifier><date>2009</date><creator>Borštnar, Simona</creator><creator>Južnič Šetina, Tanja</creator><relation>documents/doc/I/URN_NBN_SI_doc-IQ5LBH0F_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-IQ5LBH0F_001.txt</relation><format format_type="issue">1</format><format format_type="volume">13</format><format format_type="type">article</format><format format_type="extent">str. 16-18</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">25689561</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-IQ5LBH0F</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">nevtropenija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">radioterapija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Priporočila za uporabo dejavnikov rasti granulocitne vrste pri bolnikih z rakom na sistemskem zdravljenju</title></Record>